| 000 | 01811nam a22005657a 4500 | ||
|---|---|---|---|
| 003 | DOH | ||
| 005 | 20210505162300.0 | ||
| 008 | 210505b ||||| |||| 00| 0 eng d | ||
| 245 | 0 | 0 |
_aSafety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 : _ba randomised, double-blind, placebo-controlled, phase 1 trial / _cKeith J Chappell [and twenty four others] |
| 580 | _aLancet Infect Dis . 2021 Apr 19;S1473-3099 (21) 00200-0. doi: 10.1016/S1473-3099(21)00200-0. | ||
| 650 | 2 |
_aCOVID-19 Vaccines _ximmunology |
|
| 650 | 2 | _aPlacebo Effects | |
| 650 | 2 | _aAdjuvants, Immunologic | |
| 700 | 1 | _aChappell, Keith J | |
| 700 | 1 | _aMordant, Francesca L | |
| 700 | 1 | _aLi, Zheyi | |
| 700 | 1 | _aWijesundara, Danushka K | |
| 700 | 1 | _aEllenberg, Paula | |
| 700 | 1 | _aLackenby, Julia A | |
| 700 | 1 | _aCheung, Stacey T M | |
| 700 | 1 | _aModhiran, Naphak | |
| 700 | 1 | _aAvumegah, Michael S | |
| 700 | 1 | _aHenderson, Christina L | |
| 700 | 1 | _aHoger, Kym | |
| 700 | 1 | _aGriffin, Paul | |
| 700 | 1 | _aBennet, Jillian | |
| 700 | 1 | _aHensen, Luca | |
| 700 | 1 | _aZhang, Wuji | |
| 700 | 1 | _aNguyen, Thi H O | |
| 700 | 1 | _aMarrero-Hernandez, Sara | |
| 700 | 1 | _aSelva, Kevin J | |
| 700 | 1 | _aChung, Amy W | |
| 700 | 1 | _aTran, Mai H | |
| 700 | 1 | _aTapley, Peter | |
| 700 | 1 | _aBarnes, James | |
| 700 | 1 | _aReading, Patrick C | |
| 700 | 1 | _aNicholson, Suellen | |
| 700 | 1 | _aCorby, Stavroula | |
| 700 | 1 | _aHolgate, Thomas | |
| 700 | 1 | _aWines, Bruce D | |
| 700 | 1 | _a Hogarth, P Mark | |
| 700 | 1 | _aKedzierska, Katherine | |
| 700 | 1 | _aPurcell, Damian F J | |
| 700 | 1 | _aRanasinghe, Charani | |
| 700 | 1 | _aSubbarao, Kanta | |
| 700 | 1 | _aWatterson, Daniel | |
| 700 | 1 | _aYoung, Paul R | |
| 700 | 1 | _aMunro, Trent P | |
| 942 | _cJA | ||
| 999 |
_c4418 _d4418 |
||